The Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.7, n.10, article ID e47746, 11p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The causes of death on long-term mortality after acute kidney injury (AKI) have not been well studied. The purpose of the study was to evaluate the role of comorbidities and the causes of death on the long-term mortality after AKI. Methodology/Principal Findings: We retrospectively studied 507 patients who experienced AKI in 2005-2006 and were discharged free from dialysis. In June 2008 (median: 21 months after AKI), we found that 193 (38%) patients had died. This mortality is much higher than the mortality of the population of Sao Paulo City, even after adjustment for age. A multiple survival analysis was performed using Cox proportional hazards regression model and showed that death was associated with Khan's index indicating high risk [adjusted hazard ratio 2.54 (1.38-4.66)], chronic liver disease [1.93 (1.15-3.22)], admission to non-surgical ward [1.85 (1.30-2.61)] and a second AKI episode during the same hospitalization [1.74 (1.12-2.71)]. The AKI severity evaluated either by the worst stage reached during AKI (P=0.20) or by the need for dialysis (P=0.12) was not associated with death. The causes of death were identified by a death certificate in 85% of the non-survivors. Among those who died from circulatory system diseases (the main cause of death), 59% had already suffered from hypertension, 34% from diabetes, 47% from heart failure, 38% from coronary disease, and 66% had a glomerular filtration rate <60 previous to the AKI episode. Among those who died from neoplasms, 79% already had the disease previously. Conclusions: Among AKI survivors who were discharged free from dialysis the increased long-term mortality was associated with their pre-existing chronic conditions and not with the severity of the AKI episode. These findings suggest that these survivors should have a medical follow-up after hospital discharge and that all efforts should be made to control their comorbidities.
Palavras-chave
Referências
  1. Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6
  2. Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756
  3. Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002
  4. Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159
  5. Barretti P, 1997, RENAL FAILURE, V19, P253
  6. Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/01.mnh.0000109576.66112.70
  7. Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887
  8. Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b
  9. Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039
  10. Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107
  11. Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171
  12. Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034
  13. Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259
  14. Deshpande P, 2011, HEPATOL INT, V5, P751, DOI 10.1007/s12072-011-9269-8
  15. Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121
  16. Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
  17. Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295
  18. Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009
  19. Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011
  20. James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160
  21. Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46
  22. KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J
  23. Khan IH, 1997, QJM-MON J ASSOC PHYS, V90, P781
  24. Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309
  25. Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x
  26. Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011
  27. Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636
  28. Levey AS, 1999, ANN INTERN MED, V130, P461
  29. Liano F, 2010, CLIN NEPHROL, V74, pS89
  30. Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086
  31. Loef BG, 2005, J AM SOC NEPHROL, V16, P195
  32. Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9
  33. Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e
  34. Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
  35. Mehta RH, 2010, AM J CARDIOL, V106, P1728, DOI 10.1016/j.amjcard.2010.07.045
  36. Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
  37. Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160
  38. Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987
  39. Pechman KR, 2009, AM J PHYSIOL-REG I, V297, pR1358, DOI 10.1152/ajpregu.91022.2008
  40. Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359
  41. Schiffl H, 2011, INT UROL NEPHROL
  42. Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182
  43. Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479
  44. Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110
  45. Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f
  46. Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322
  47. Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016
  48. WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230